Modulation of expression of superantigens by human transferrin and lactoferrin: A novel mechanism in host-streptococcus interactions

Journal of Infectious Diseases

Volumn 191, Issue 12, 2005, Pages 2121-2129

  Kansal, Rita G ^a   Aziz, Ramy K ^a   Kotb, Malak ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOTRANSFERRIN; BACTERIAL ANTIGEN; CYSTEINE PROTEINASE; EXOTOXIN; IRON; LACTOFERRIN; SPEA PROTEIN; SPEB PROTEIN; STREPTOCOCCAL PYROGENIC EXOTOXIN; SUPERANTIGEN; TRANSFERRIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATE; GENE; GENE EXPRESSION; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; MUCOSA; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN; SPEA GENE; SPEB GENE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION;

ANTIGENS, BACTERIAL; APOPROTEINS; BACTERIAL PROTEINS; DOWN-REGULATION; EXOTOXINS; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; LACTOFERRIN; LEUKOCYTES, MONONUCLEAR; MEMBRANE PROTEINS; STREPTOCOCCUS PYOGENES; SUPERANTIGENS; TRANSFERRIN; UP-REGULATION;

EID: 20444427567     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/430386     Document Type: Article

References (41)

1. Low DE, Schwartz B, McGeer A. The reemergence of severe group A streptococcal disease: an evolutionary perspective. In: Scheld WM, Armstrong D, Hughes JM, eds. Emerging infections. Vol. 1. Washington, DC: American Society for Microbiology Press, 1997:93-123.
2. Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 2000; 13:470-511.
3. Chatellier S, Ihendyane N, Kausal RG, et al. Genetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases. Infect Immun 2000; 68:3523-34.
4. Kotb M. Bacterial pyrogenic exotoxins as superantigens. Clin Microbiol Rev 1995; 8:411-26.
5. Welcher BC, Carra JH, DaSilva L, et al. Lethal shock induced by streptococcal pyrogenic exotoxin A in mice transgenic for human leukocyte antigen-DQ8 and human CD4 receptors: implications for development of vaccines and therapeutics. J Infect Dis 2002; 186:501-10.
6. Cleary PP, McLandsborough L, Ikeda L, Cue D, Krawczak J, Lam H. High-frequency intracellular infection and erythrogenic toxin A expression undergo phase variation in M1 group A streptococci. Mol Microbiol 1998; 28:157-67.
7. Norrby-Teglund A, Kotb M. Host-microbe interactions in the pathogenesis of invasive group A streptococcal infections. J Med Microbiol 2000; 49:849-52.
8. Ashbaugh CD, Wessels MR. Absence of a cysteine protease effect on bacterial virulence in two murine models of human invasive group A streptococcal infection. Infect Immun 2001; 69:6683-8.
9. Collin M, Olsen A. Extracellular enzymes with immunomodulating activities: variations on a theme in Streptococcus pyogenes. Infect Immun 2003; 71:2983-92.
10. Saouda M, Wu W, Conran P, Boyle MD. Streptococcal pyrogenic exotoxin B enhances tissue damage initiated by other Streptococcus pyogenes products. J Infect Dis 2001; 184:723-31.
11. Rasmussen M, Bjorck L. Proteolysis and its regulation at the surface of Streptococcus pyogenes. Mol Microbiol 2002; 43:537-44.
12. Chaussee MS, Liu J, Stevens DL, Ferretti JJ. Genetic and phenotypic diversity among isolates of Streptococcus pyogenes from invasive infections. J Infect Dis 1996; 173:901-8.
13. Holm SE, Norrby A, Bergholm AM, Norgren M. Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989. J Infect Dis 1992; 166:31-7.
14. Nakashima K, Ichiyama S, Iinuma Y, et al. A clinical and bacteriologic investigation of invasive streptococcal infections in Japan on the basis of serotypes, toxin production, and genomic DNA fingerprints. Clin Infect Dis 1997; 25:260-6.
15. Talkington D, Schwartz B, Black C, et al. Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome. Infect Immun 1993; 61:3369-74.
16. Kansal RG, Nizet V, Jeng A, Chuang WJ, Kotb M. Selective modulation of superantigen-induced responses by streptococcal cysteine protease. J Infect Dis 2003; 187:398-407.
17. Kazmi SU, Kansal R, Aziz RK, et al. Reciprocal, temporal expression of SpeA and SpeB by invasive M1T1 group a streptococcal isolates in vivo. Infect Immun 2001; 69:4988-95.
18. Aziz RK, Pabst MJ, Jeng A, et al. Invasive M1T1 group A Streptococcus undergoes a phase-shift in vivo to prevent proteolytic degradation of multiple virulence factors by SpeB. Mol Microbiol 2004; 51:123-34.
19. Raeder R, Harokopakis E, Hollingshead S, Boyle MD. Absence of SpeB production in virulent large capsular forms of group A streptococcal strain 64. Infect Immun 2000; 68:744-51.
20. Kotb M, Norrby-Teglund A, McGeer A, et al. An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat Med 2002; 8:1398-404.
21. Xiao R, Kisaalita WS. Iron acquisition from transferrin and lacloferrin by Pseudomonas aeruginosa pyoverdin. Microbiology 1997; 143:2509-15.
22. Miehlke S, Reddy R, Osato MS, Ward PP, Conneely OM, Graham DY. Direct activity of recombinant human lactoferrin against Helicobacter pylori. J Clin Microbiol 1996; 34:2593-4.
23. Caparon MG, Geist RT, Perez-Casal J, Scott JR. Environmental regulation of virulence in group A streptococci: transcription of the gene encoding M protein is stimulated by carbon dioxide. J Bacteriol 1992; 174:5693-701.
24. McIver KS, Heath AS, Scott JR. Regulation of virulence by environmental signals in group A streptococci: influence of osmolarity, temperature, gas exchange, and iron limitation on emm transcription. Infect Immun 1995; 63:4540-2.
25. Smoot JC, Barbian KD, Van Gompel JJ, et al. Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks. Proc Natl Acad Sci USA 2002; 99:4668-73.
26. Dalton TL, Scott JR. CovS inactivates CovR and is required for growth Linder conditions of general stress in Streptococcus pyogenes. J Bacteriol 2004; 186:3928-37.
27. Broudy TB, Pancholi V, Fischetti VA. Induction of lysogenic bacteriophage and phage-associated toxin from group a streptococci during coculture with human pharyngeal cells. Infect Immun 2001; 69:1440-3.
28. Broudy TB, Pancholi V, Fischetti VA. The in vitro interaction of Streptococcus pyogenes with human pharyngeal cells induces a phage-encoded extracellular DNase. Infect Immun 2002; 70:2805-11.
29. Banks DJ, Lei B, Musser JM. Prophage induction and expression of prophage-encoded virulence factors in group A Streptococcus serotype M3 strain MGAS315. Infect Immun 2003; 71:7079-86.
30. Voyich JM, Sturdevant DE, Braughton KR, et al. Genome-wide protective response used by group A Streptococcus to evade destruction by human polymorphonuclear leukocytes. Proc Natl Acad Sci USA 2003; 100:1996-2001.
31. Ekins A, Niven DP. Production of transferrin receptors by Histophilus ovis: three of five strains require two signals. Can J Microbiol 2001; 47:417-23.
32. Evans RW, Oakhill JS. Transferrin-mediated iron acquisition by pathogenic Neisseria. Biochem Soc Trans 2002; 30:705-7.
33. Bog YS, Andresen LO, Bastholm L, Elling F, Angen O, Heegaard PM. The transferrin receptor of Actinobacillus pleuropneumoniae: quantitation of expression and structural characterization using a peptide-specific monoclonal antibody. Vet Microbiol 2001; 81:51-64.
34. Modun B, Morrissey J, Williams P. The staphylococcal transferrin receptor: a glycolytic enzyme with novel functions. Trends Microbiol 2000; 8:231-7.
35. Taylor JM, Heinrichs DE. Transferrin binding in Staphylococcus aureus: involvement of a cell wall-anchored protein. Mol Microbiol 2002;43: 1603-14.
36. Perkins-Balding D, Ratliff-Griffin M, Stojiljkovic I, et al. Iron transport systems in Neisseria meningitidis. Microbiol Mol Biol Rev 2004; 68: 154-71; table of contents.
37. Andrews SC, Robinson AK, Rodriguez-Quinones F. Bacterial iron homeostasis. FEMS Microbiol Rev 2003; 27:215-37.
38. Dubnau E, Smith I. Mycobacterium tuberculosis gene expression in macrophages. Microbes Infect 2003; 5:629-37.
39. Roop RM 2nd, Bellaire BH, Valderas MW, Cardelli JA. Adaptation of the Brucellae to their intracellular niche. Mol Microbiol 2004; 52:621-30.
40. Schmitt MP, Talley BG, Holmes RK. Characterization of lipoprotein IRP1 from Corynebacterium diphtheriae, which is regulated by the diphtheria toxin repressor (DtxR) and iron. Infect Immun 1997; 65:5364-7.
41. Schmitt MP, Holmes RK. Cloning, sequence, and footprint analysis of two promoter/operators from Corynebacterium diphtheriae that are regulated by the diphtheria toxin repressor (DtxR) and iron. J Bacteriol 1994; 176:1141-9.